Cantargia AB
STO:CANTA

Watchlist Manager
Cantargia AB Logo
Cantargia AB
STO:CANTA
Watchlist
Price: 1.812 SEK -2.42% Market Closed
Market Cap: 332.8m SEK
Have any thoughts about
Cantargia AB?
Write Note

Cantargia AB
Other Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Cantargia AB
Other Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Cantargia AB
STO:CANTA
Other Current Liabilities
kr894k
CAGR 3-Years
-19%
CAGR 5-Years
8%
CAGR 10-Years
N/A
Biogaia AB
STO:BIOG B
Other Current Liabilities
kr51.3m
CAGR 3-Years
19%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
Other Current Liabilities
kr91.1m
CAGR 3-Years
42%
CAGR 5-Years
16%
CAGR 10-Years
N/A
Vitrolife AB
STO:VITR
Other Current Liabilities
kr192m
CAGR 3-Years
48%
CAGR 5-Years
27%
CAGR 10-Years
9%
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Other Current Liabilities
kr6.4B
CAGR 3-Years
9%
CAGR 5-Years
11%
CAGR 10-Years
24%
BioArctic AB
STO:BIOA B
Other Current Liabilities
kr49.3m
CAGR 3-Years
-17%
CAGR 5-Years
-32%
CAGR 10-Years
N/A
No Stocks Found

Cantargia AB
Glance View

Market Cap
332.8m SEK
Industry
Biotechnology

Cantargia AB is a holding company, which engages in the development of antibody-based cancer treatment. The company is headquartered in Lund, Skane. The company went IPO on 2015-03-17. The firm is engaged in the development of a therapy for the treatment of cancer by targeting a cell-surface receptor on malignant stem cells, through the development of antibody therapeutics for eradication of malignant stem cells. Cantargia AB uses the Interleukin-1 receptor accessory protein (IL1RAP), as the target for development of a novel antibody-based therapy for leukemia.

CANTA Intrinsic Value
1.024 SEK
Overvaluation 44%
Intrinsic Value
Price

See Also

What is Cantargia AB's Other Current Liabilities?
Other Current Liabilities
894k SEK

Based on the financial report for Sep 30, 2024, Cantargia AB's Other Current Liabilities amounts to 894k SEK.

What is Cantargia AB's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 5Y
8%

Over the last year, the Other Current Liabilities growth was -34%. The average annual Other Current Liabilities growth rates for Cantargia AB have been -19% over the past three years , 8% over the past five years .

Back to Top